Find Your Next Blockbuster - Regulatory Exclusivity and Government Approval of Drugs

Why is this course free?

This course was developed to help DrugPatentWatch users better understand the complexities and common strategies around brand erosion and generic entry.

The positive responses received made it apparent that the course would be useful to others in the industry, we decided to make it available for free.

Please help spread the word.

Tell your friends about this free resource

Regulatory Exclusivity and Government Approval of Drugs

Next: Analyzing patents and litigation →

Get the Companion Text: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Contents

• Introduction
• About your instructor
• About DrugPatentWatch
• Disclaimer
• Small molecule and biologic drugs
• Generic vs biosimilar drugs
• 505(b)(2) drugs
• Patents and other forms of IP
• Trade Secrets
• Trademarks
• Regulatory Exclusivity and Government Approval of Drugs
• Analyzing patents and litigation
• Making the business case: market size and quality
• Drug Commercialization: Branded Drug Launch and Lifecycle Management Strategies
• Generic Portfolio Management: Prioritizing Generic Drug Launches
• Conclusion
• Conference Presentation: Generic Portfolio Management, Partnering with Brands, and Staying Competitive
• Conference Presentation: Evaluating Innovative Portfolios and Preparing for Generic Entry
• Conference Presentation: Finding and Evaluating Generic Drug Market Entry Opportunities